U.S. Chess Champion Backs Out Of Abivax and Casey's, But Keeps Outpacing the S&P 500
Complete. Here is the key summaryU.S. Chess Champion Hikaru Nakamura closed positions in Abivax (ABVX) and Casey's General Stores (CASY) to maintain his portfolio's outperformance against the S&P 500. He sold ABVX for a 16.49% gain and CASY at a 9.14% loss. Overall, Nakamura achieved a 30.8% total return with an alpha of 15.4% over the benchmark index.
U.S. chess champion Hikaru Nakamura has closed two stocks to help keep his TipRanks investment portfolio outperform the S&P 500.
TipRanks Welcomes a New ETF – NYSE:RANK
High conviction AMZN bears now have this Tradr ETFABVX and CASY
On June 30, Hikaru closed his position in Abivax (ABVX). He bought 85 shares in the biotech on January 9, 2026 at a price of $115.94, It represented 8.93% of his holdings. At the time he said: "French biotech up 1700% in 2025 on the back of Obefazimod results. Ulcerative colitis is a huge market, projections of 10B in revenue per year once the drug is publicly available on top of being a huge buyout target."
Hikaru ended his position with a healthy gain of 16.49%.
On June 23, Hikaru closed his position in Casey's General Stores (CASY). Hikaru bought 15 shares at a purchase price of $780 earlier that month. It represented 10% of his overall holdings.
Although Hikaru didn't identify the reasons behind the purchase, he was likely to have been attracted by the stock's 48.6% hike in the year-to-date. That has been helped by higher fuel margins as gas prices rise and more demand for convenience food like pizza.
However, he ended his position with a loss of 9.14%.
Strong Overall Returns
Overall, Hikaru has notched up a 30.8% gain, has an 11.79% average return on his transactions and has achieved 12 out of 24 profitable transactions. His alpha over the S&P 500 is 15.4%.